Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Compumedics Limited ( (AU:CMP) ) has shared an update.
Compumedics Limited has secured a new $4.9 million MEG sales order from Beijing Normal University, bringing its total MEG sales to $25 million. This order strengthens Compumedics’ leadership in the Chinese neuro-imaging market and supports its growth strategy, with plans for further expansion in China, North America, and Europe. The deal highlights the company’s innovative MEG products and positions it for sustainable revenue growth through FY27.
The most recent analyst rating on (AU:CMP) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Compumedics Limited stock, see the AU:CMP Stock Forecast page.
More about Compumedics Limited
Compumedics Limited is a company specializing in neuro-imaging technology, particularly magnetoencephalography (MEG) systems, and is focused on expanding its market presence in Asia and North America.
Average Trading Volume: 129,951
Technical Sentiment Signal: Buy
Current Market Cap: A$70.92M
Find detailed analytics on CMP stock on TipRanks’ Stock Analysis page.